Chiro-Zyme

T1 To T7 Rsp

F
N+ Score54
Vitamins & MineralsServing: 2 Capsule(s)Type: Other Combinations

Chiro-Zyme T1 To T7 Rsp is a combination supplement featuring 9 distinct botanical ingredients per two-capsule serving. Key ingredients include Black Cherry (90mg), Radish (90mg), Basil (80mg), Uva Ursi (80mg), and Sarsaparilla (80mg), alongside a Proprietary Plant Enzyme Blend (68mg). With an N+ Score of 54 (Grade F), this product is classified as below-average quality. The individual dosages of the botanical ingredients are generally low and likely underdosed compared to amounts typically studied for specific therapeutic effects. The use of a proprietary blend for the enzymes further limits transparency. This product may be considered by those interested in a broad spectrum of botanicals, though efficacy at these doses is uncertain.

About This Product

T1 To T7 Rsp by Chiro-Zyme is a vitamins & minerals supplement containing 9 active ingredients. It has earned an N+ Score of 54/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity83/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (9 ingredients)

IngredientAmountDose Adequacy
Uva Ursi80.000 mgN/A
Sarsaparilla80.000 mgN/A
Mullein40.000 mgN/A
Black Cherry90.000 mgN/A
Rose Hip20.000 mgN/A
Horehound30.000 mgN/A
Proprietary Plant Enzyme Blend68.000 mgN/A
Radish90.000 mgN/A
Basil80.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.